Clinical trial

Optimizing Reversal of HIV Latency With Combination Therapy

NCT06240520

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-04-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2024-04-01Date precision: month

Registry last updated2024-02-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hivunresolved

Interventions

Panobinostat 20 MG Oral CapsuleDRUG · verified · RxNorm: panobinostat 20 MG Oral Capsule

Pyrimethamine 200mg Oral TabletDRUG

Lenalidomide 25 MG Oral CapsuleDRUG · verified · RxNorm: lenalidomide 25 MG Oral Capsule

Sponsors & collaborators

Erasmus Medical Centerlead sponsor

ZonMw: The Netherlands Organisation for Health Research and Developmentcollaborator

AIDSfondscollaborator

Mapped research locations

AmsterdamNetherlands1 UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06240520 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.